郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Remodeling Intestinal Microbiota Alleviates Severe Combined Hyperlipidemia-Induced Nonalcoholic Steatohepatitis and Atherosclerosis in LDLR-/- Hamsters.

期刊：Research (Washington, D.C.)发表年份：2024作者：Guolin Miao; Jiabao Guo; Wenxi Zhang; Pingping Lai; Yitong Xu; Jingxuan Chen; Lianxin Zhang; Zihao Zhou; Yufei Han; Gonglie Chen; Jinxuan Chen; Yijun Tao; Lemin Zheng; Ling Zhang; Wei Huang; Yuhui Wang; Xunde Xian
阅读更多 →

代谢疾病In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays.

期刊：European journal of pharmacology发表年份：2024作者：Chiara Sturaro; Chiara Ruzza; Federica Ferrari; Pietro Pola; Michela Argentieri; Alessia Frezza; Erika Marzola; Barbara Bettegazzi; Stefano Cattaneo; Claudio Pietra; Davide Malfacini; Girolamo Calò
阅读更多 →

代谢疾病Discovery of novel glucagon-like peptide 1/cholecystokinin 1 receptor dual agonists.

期刊：European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences发表年份：2024作者：Zhou Chenxu; Sun Lidan; Hu Guoqiang; Gong Binbin; Wang Ting; Sun Xiaoyi; Long Qian
阅读更多 →

代谢疾病Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes.

期刊：Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie发表年份：2024作者：Jongmin Yoon; Don-Gil Lee; Haengjin Song; Dahae Hong; Ji Soo Park; Changhee Hong; Kyung Mi An; Jung Woo Lee; Joon-Tae Park; Hongchul Yoon; Jihoon Tak; Sang Geon Kim
阅读更多 →